From: The adherence to and utility of the Global Initiative for Chronic Obstructive Lung Disease guidelines for treating COPD among pulmonary specialists: a retrospective analysis
Inhaled Corticosteroid Usage
Group A
Group B
Group C
Group D
ICS + LABA + LAMA
30.60%
47.77%
30.77%
63.33%
ICS + LABA
24.20%
17.92%
15.38%
15.71%
ICS only
1.42%
1.19%
3.85%
0.48%
ICS + LAMA
0.00%
0.43%
Total
56.23%
67.32%
50.00%
79.52%